Does lower eGFR reduce homocysteine clearance and raise cardiovascular risk?

The relationship between renal function, metabolic clearance, and cardiovascular health is well-documented, with the kidneys serving as a primary regulator of plasma homocysteine and a critical determinant of systemic vascular health.

Renal clearance and homocysteine

The kidneys are responsible for approximately 70% of homocysteine clearance in healthy individuals. This occurs primarily through glomerular filtration followed by metabolic processing in the proximal tubular epithelial cells via the transsulfuration pathway.

• eGFR and accumulation: As the estimated glomerular filtration rate (eGFR) declines, renal clearance of homocysteine drops significantly. There is a strong inverse correlation between GFR and total homocysteine (r = -0.68, P < 0.001).
• Prevalence: In patients with chronic kidney disease (CKD), the impaired filtration and tubular degradation lead to hyperhomocysteinemia in 85–100% of cases. When eGFR falls significantly, extra-renal pathways (such as the liver) are insufficient to prevent plasma accumulation.

Endothelial dysfunction mechanisms

Reduced eGFR creates a systemic environment hostile to the vascular endothelium, driven by the accumulation of uremic toxins.

• Nitric oxide inhibition: Toxins like asymmetric dimethylarginine (ADMA) accumulate as GFR drops, acting as potent inhibitors of endothelial nitric oxide synthase (eNOS). This reduces nitric oxide bioavailability, impairing vascular tone and promoting thrombosis.
• Oxidative stress: Lower eGFR is linked to increased reactive oxygen species (ROS) that uncouple eNOS and damage the endothelial glycocalyx. This is evidenced by higher levels of adhesion molecules (ICAM-1, VCAM-1) and markers of glycocalyx degradation like syndecan-1.

Cardiovascular risk outcomes

Lower eGFR is an independent and robust predictor of major adverse cardiovascular events (MACE) and cardiovascular mortality.

• Risk thresholds: Risks rise sharply as eGFR falls below 60 mL/min/1.73m². At these levels, hazard ratios for cardiovascular events typically range from 1.4 to 2.3 compared to those with normal renal function.
• Rate of decline: The trajectory of renal decline is also critical; a >30% decline in eGFR markers has been associated with a hazard ratio of 2.48 for cardiovascular disease and mortality.

Bottom line

A lower eGFR directly reduces the renal clearance of homocysteine, leading to systemic accumulation. This state, alongside the retention of uremic toxins, triggers endothelial dysfunction and oxidative stress, independently increasing the risk of cardiovascular events and mortality.